SCHEMBL19707634

SCHEMBL19707634

O=C(Nc1ccc(Br)cc1)N(c1ccc(Br)cc1)C(O)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ TNIK Q9UKE5 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ KCNH2 Q12809 1/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ FPR2 P25090 1/20 0.39
▸ EPHX1 P07099 1/20 0.39
▸ CHRNA1 P02708 1/20 0.39
▸ CHRNG P07510 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3588245 0.69 ATM (0.56) RAB9ANPC1ALDH1A1SMN1; SMN2TDP1
SCHEMBL19707595 0.68 MEN1 (0.50) RAB9ANPC1ALDH1A1SMN1; SMN2TDP1
SCHEMBL19707659 0.68 NPY5R (0.56) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL19707210 0.68 FPR2 (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2TDP1
SCHEMBL14413756 0.67 RAB9A (1.00) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL19707706 0.67 MEN1 (0.45) RAB9ANPC1ALDH1A1KMT2AKCNH2
SCHEMBL19708112 0.66 MEN1 (0.47) RAB9ANPC1ALDH1A1SMN1; SMN2TDP1
SCHEMBL31637520 0.66 RAB9A (0.96) RAB9ANPC1ALDH1A1SMN1; SMN2TDP1
SCHEMBL19707295 0.65 MEN1 (0.46) RAB9ANPC1ALDH1A1TDP1KMT2A
SCHEMBL22777886 0.64 KDM4E (0.94) RAB9ANPC1ALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017214505-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2017-12-14 — — WO disclosed
Send feedback